CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage

CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage

Bladder cancer (BCa) is the ninth most commonly diagnosed cancer worldwide. Although there are several well-established molecular and immunological classifications, markers for tumor cells and immune cells that are associated with prognosis are still needed. The chemokine CC motif ligand 2 (CCL2) co...

Full description

Bibliographic Details
Main Authors: Markus Eckstein, Elena Epple, Rudolf Jung, Katrin Weigelt, Verena Lieb, Danijel Sikic, Robert Stöhr, Carol Geppert, Veronika Weyerer, Simone Bertz, Astrid Kehlen, Arndt Hartmann, Bernd Wullich, Helge Taubert, Sven Wach
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cancers
Subjects:
CCL2
bladder cancer
prognosis
tumor cells
immune cells
lymph node stage
Online Access:https://www.mdpi.com/2072-6694/12/5/1253

Internet

https://www.mdpi.com/2072-6694/12/5/1253

Similar Items